-+ 0.00%
-+ 0.00%
-+ 0.00%

MORESCO (TSE:5018) Q2 Earnings Reinforce Margin Recovery Story

Simply Wall St·10/16/2026 09:27:10
Listen to the news

MORESCO walked into this Q2 2027 report with momentum already behind it, after strong trailing earnings growth and a P/E of 10.8x that sat below both the Japan chemicals industry and peer averages. The headline this quarter is clear: profitability held up, with basic earnings per share at ¥85.47 on revenue of ¥10,319m, keeping the recent earnings reset intact.

The stock closed today at ¥2,983, even as the latest figures point to an earnings story that still leans on improving margins rather than just top line noise. Recent price action appears more like a mood check than a hard read of the numbers.

Like the look of MORESCO’s earnings resilience and below industry P/E but want a wider pool of companies pairing solid profitability with sturdier balance sheets? Line this quarter up against stocks in our list of solid balance sheet and fundamentals stocks (21 results).

Q2 2027 Earnings Summary

  • Revenue (Q2 2027 vs Q2 2026): ¥10,319m vs. ¥8,349m (up about 23.6%)
  • Net Income (Excl. Extra Items, Q2 2027 vs Q2 2026): ¥785m vs. ¥269m (up about 191.8%)
  • Basic EPS (Q2 2027 vs Q2 2026): ¥85.47 vs. ¥29.32 (up about 191.5%)
  • Trailing Net Profit Margin (Last 12 Months vs Prior Year): 6.7% vs. 2.8% (higher margin over the latest 12 month period)

Earnings tell you how MORESCO performed on paper this quarter, but cash flows show the money that actually comes through the door and can support the business over time. When you focus on MORESCO's cash generation and plug it into a discounted cash flow model, the stock could be a clear 27% undervalued.

TSE:5018 Trailing 12-Month Earnings & Revenue History as at Oct 2026
TSE:5018 Trailing 12-Month Earnings & Revenue History as at Oct 2026

MORESCO’s bullish narrative meets stronger earnings base

For investors leaning positive on MORESCO, the broad story lines up with the latest print. Revenue of ¥10,319m against ¥8,349m a year earlier and basic EPS of ¥85.47 versus ¥29.32 both point to a business selling more and keeping more of every yen. A trailing net margin at 6.7% compared with 2.8% also fits the picture of a specialty supplier gaining earnings power rather than simply riding volume.

Bearish worries on cyclicality look less urgent for now

Concerns about industrial cyclicality and pricing pressure still matter, but the near term numbers take some sting out of that argument. Net income excluding extra items at ¥785m versus ¥269m and a higher trailing margin suggest MORESCO has recently had enough pricing and mix support to offset typical input cost and end market worries. The share price gain over the past 90 days, up about 43%, also indicates recent trading has leaned toward acknowledging that operational progress.

After a period of operational progress and a 43% price move in just 90 days, it is fair to ask whether MORESCO’s unstable dividend track record is an isolated quirk or a red flag that hints at deeper balance sheet or cash flow fragility. Review the full risk analysis for MORESCO which shows 1 important warning sign

Hunt Quiet Price Dislocations

MORESCO just reported earnings with a sharp price move that raised questions about durability and balance sheet strength. The real opportunity is in stocks that could be undervalued before the market corrects their pricing.

  • Company 1 - 19% below our estimate - monetises real estate expertise by structuring renewables, logistics and lodging projects for asset owners seeking turnkey development.
  • Company 2 - 26% below our estimate - supplies critical photomasks that chipmakers adopt when they shift production to new process nodes and packaging formats.
  • Company 3 - 37% below our estimate - builds virtual talent franchises that corporations tap when they want digital characters fronting events, campaigns and interactive content.

Those are three of them. See the full list of 14 companies trading below our fair value estimates →

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.